Clinical Trials Logo

Clinical Trial Summary

To elucidate the relationship of chewing miswak sticks on the H. Pylori infection in the oral cavity.The study would be conducted at the Faculty of Dentistry, Kuwait University. Oral plaque samples would be obtained from those patients who are willing to participate. As a part of the initial screening the plaque samples would be collected and sent for screening of oral microbiota to the Microbiology Department of Faculty of Dentistry, Kuwait University. Here, the basic microbial culturing (rapid urease test) would be performed for detecting the presence of oral H.Pylori. Volunteers who are tested positive for H. Pylori infection through the rapid urease test would be invited to participate in the study.


Clinical Trial Description

Ethical aspects The experimental protocol was approved by the Health Science Center (HSC) ethical committee of Kuwait University (VDR/ED/3331) and is registered at ClinicalTrials.gov as NCT02418520 (16/04/2015). Research was conducted according to the principles outlined in the declaration of Helsinki on human medical experimentation. Written informed consent was obtained from all participants and is presented in accordance to the consolidated standards of reporting trials (CONSORT) guidelines. Study Design This was an experimental study with a randomized, cross-over, single blind design. Study sample and Data collection This study was conducted among regular patients attending the Dental Center at Kuwait University, Kuwait. Patient recruitment started in February and was completed by the end of August 2019. The PICO (P = Patient population; I = Intervention of interest; C = Comparative intervention; O = Outcome) question for this study was, "for subjects under different fasting conditions (P), what is the effect of using miswak chewing sticks along with toothbrush (I) versus using only toothbrush (C) on the oral H. pylori counts (O)?". Volunteering patients were briefed on the study components and informed consent was obtained from them. Salivary and plaque samples were collected for PCR screening to detect the presence of H. pylori. The inclusion criteria were: 1) subjects with detectable levels of H. pylori in either plaque or salivary samples; 2) no evidence of periodontitis; and, 3) with at least 24 teeth. Subjects who received antibiotic therapy or proton-pump inhibitors within the past three months were excluded from the study. Recruitment of study participants and grouping This study included 20 subjects who were on 12-hour fasting (fasting group) and 20 subjects who were not fasting (non-fasting group). Non-fasting group subjects were recruited between February and April and fasting group subjects were recruited between May and June 2018 (holy month of Ramadan). At baseline (T0), each subject was assigned numbers based on the chronological order of enrolment in the study. Both, the fasting and the non-fasting subjects were randomly subdivided into Group-1 and Group-2 (n=10 each). Randomized assignment of the subjects was carried out by a random binary outcome of a dice, even or odd numbers. The examiners were kept unaware of the participant allocation. Group-1 subjects were instructed to use both toothbrush and miswak (TB+M) for two weeks (T1) and only toothbrush (TB) for the next two weeks (T2); and, Group-2 subjects were asked to use only TB during T1 and TB+M during T2, for both the fasting and the non-fasting groups. Participants were given instructions on how to use miswak (five finger-grip, scrub technique, for 15 mins, twice daily21) and TB (modified Bass technique, for two minutes, twice daily) by a single investigator (JKB). Plaque and salivary samples were collected at T0, T1 and T2. Questionnaire The subjects were interviewed and information were collected on their socio-demographic characteristics (age, gender, education, employment and income), presence of selected medical conditions (hypertension, diabetes and current medications), smoking status and dental characteristics (daily brushing frequency and previous dental visit). Clinical Examination At baseline (T0), three trained and calibrated examiners performed the clinical examinations using a mouth mirror and a manual periodontal probe (CP11 Hu Friedy, Europe), with the patient in semi-supine position on the dental chair (A-dec, Newberg, OR, USA). The clinical examinations assessed the Silness & Löe plaque index (PI), the Löe & Silness gingival index (GI), the clinical attachment loss (CAL), the probing depth (PD) and the bleeding on probing (BOP) (inter/intra examiner reliability >80%). These measurements were performed on six surfaces (midlingual/palatal, distolingual/palatal, mesiolingual/palatal, distobuccal, midbuccal, and mesiobuccal) of all teeth. Number of missing teeth were recorded. Sample collection procedure Plaque and salivary samples were collected from the subjects at T0, T1 and T2. Plaque samples were taken from gingival crevice at deepest pocket reading and removed from the clinical site using a sterile universal curette. The sampling area were isolated using salivary ejectors and gently dried by air. The tip of the curette was inserted into the depths of crevice/pocket, moved coronally while in contact with the tooth surface, to remove both sub and supragingival plaque. The samples were then immersed in 0.5 ml sterile distilled water in Eppendorf tubes (epTIPS Standard, Eppendorf AG, Hamburg, Germany). For the collection of stimulated salivary samples, subjects were requested to chew on paraffin wax and expectorated into a plastic funnel connected to a graded measuring cylinder. About 3 ml of saliva was collected from each subject. Immediately after collection, the sample tubes were placed in a container filled with crushed ice and transported to the Oral Microbiology lab for preserving at -800C. Bacterial culture H. pylori JA1 strain was obtained from the Faculty of Medicine, KUWAIT University. The bacterial strain was grown on trypticase soy agar supplemented with defibrinated sheep blood (5%) at 37 degree Celsius in microaerophilic conditions. DNA purification Saliva and plaque samples were brought to the laboratory on ice. After vortexing for 1 minute at 12000 × g, the supernatant was removed, and the pellets were stored at -80°C. DNA from the pellets was purified by using a DNeasy DNA purification Kit (Qiagen, Germany) according to manufacturer's instructions. Briefly, the pellets were treated with lysis buffer and proteinase-K at 56 degree Celsius for 1 h. DNA from lysed samples were applied onto a spin column and washed. Purified DNA was eluted using nuclease free water and the DNA concentrations were measured by UV spectrophotometry method using NanoDropTM 1000. Genomic DNA from H. pylori JA1 was purified by using the same method. Quantitative real-time polymerase chain reaction (qPCR) After purifying the DNA from the samples, the quantities of H. pylori were measured by SYBR Green quantitative real-time PCR method using H. pylori species-specific primers for ureA gene: ureA-F: 5'-CGTGGCAAGCATGATCCAT-3' and ureA-R: 5'- GGGTATGCACGGTTACGAGTTT-3' 44. The qPCR reaction mixture (25 µl) contained 12.5 µl SYBR Green master mix (Power SYBR Green® Kit, Applied Biosystems), 1.0 µl each of forward and reverse primer (0.4 µM), 5.0 µl DNA template and 5.5 µl H2O. The thermal profile was as follows: an initial denaturation at 95°C for 10min, 40 cycles of 95°C for 15-30s, 55 °C for 30s and 72 °C for 30s. Fluorescent signal acquisition was set at the elongation step of each cycle. All qPCR reactions were run on ABpplied Biosystems® Fast 7500 Real-Time PCR machine. Sequence Detection Systems (SDS) (software version 2.3) was used for data analysis. Serially diluted genomic DNA from H. pylori JA1 was used the reactions for plotting the Ct values against deduced bacterial cell concentration (cells/mL) for each species and to construct standard curves using the above software. All the measurements were taken in triplicate for samples, standards and controls. Data management and statistical analysis A reduction in the H. pylori count using either TB+M or TB under different fasting conditions was the primary outcome of interest in this study. As no a priori information on the effect of miswak on H. pylori was available, the sample size was calculated to detect a 50% difference between groups, assuming a mean 30% reduction in H. pylori counts between the groups, with a standard deviation of 15%. To obtain a power of 80% and for a risk alpha of 0.05, 17 patients per group were required, which was rounded-off to 20, to account for any potential dropouts. The difference in the microbial counts were computed between T0, T1 and T2. Mann-Whitney U-test or Kruskal-Wallis test (continuous dependent variable) and chi-square test (categorical dependent variable) were used to assess the differences in the general characteristics between the two groups. Distribution of H. pylori between the groups were explored for normality using the Kolmogorov-Smirnov and Shapiro-Wilk tests. The data was not normally distributed, so the intragroup change in H. pylori counts was evaluated with the Wilcoxon signed rank test and the intergroup comparisons were made using the Mann-Whitney U-test. Spearman's test was used to assess the correlation between the H. pylori counts (1x103cells/mL) in plaque/salivary samples and the clinical periodontal parameters at baseline. The level of significance was set to p<0.05. All statistical analyses were carried out using SPSS 26.0 (IBM Corp., Armonk, NY, USA). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02418520
Study type Interventional
Source Kuwait University
Contact
Status Completed
Phase N/A
Start date October 1, 2019
Completion date December 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT04712630 - Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft N/A
Completed NCT06127069 - Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device N/A
Completed NCT04964167 - Indocyanine-green Mediated Photosensitizer VS Aloe Vera Gel: Adjunct Therapy to Scaling and Root Planing in Patients With Chronic Periodontitis Phase 4
Completed NCT05906797 - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis. N/A
Recruiting NCT03997552 - NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration N/A
Not yet recruiting NCT05530252 - Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis Phase 4
Completed NCT04881357 - Antiplaque/Antigingivitis Effect of Lacer Oros Integral N/A
Recruiting NCT03790605 - A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis Phase 3
Enrolling by invitation NCT04971174 - Outcomes of Periodontal Regenerative Treatment
Not yet recruiting NCT05568290 - Interleukin-38 Levels in Individuals With Periodontitis
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Recruiting NCT03997578 - Non-incised Papillae Surgical Approach (NIPSA) and Connective Tissue Graft Plus Emdogain for Periodontal Defects N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Enrolling by invitation NCT04956211 - Periodontal Treatment and Ischemic Stroke N/A
Recruiting NCT05971706 - Ozone Application in Periodontal Treatment N/A
Recruiting NCT06099574 - A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
Completed NCT04402996 - Meteorin-like Levels in Individuals With Periodontitis
Active, not recruiting NCT05311657 - Oral Health and Severe COPD
Not yet recruiting NCT05643287 - The Effect of Time on the Outcome of Periodontal Treatment. N/A
Not yet recruiting NCT05995431 - Impact of Bruxism in the Outcome of Subgingival Instrumentation for the Management of Stage 2 and Stage 3 Periodontitis. N/A